Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 12823 | 46.38 |
09:34 ET | 964 | 46.355 |
09:36 ET | 2411 | 45.98 |
09:38 ET | 1100 | 45.91 |
09:39 ET | 923 | 45.82 |
09:41 ET | 2294 | 45.83 |
09:43 ET | 523 | 45.83 |
09:45 ET | 2593 | 45.9 |
09:48 ET | 2198 | 45.97 |
09:50 ET | 1218 | 45.885 |
09:52 ET | 900 | 45.94 |
09:54 ET | 1434 | 45.96 |
09:56 ET | 1800 | 46.06 |
09:57 ET | 1390 | 45.96 |
09:59 ET | 200 | 46.01 |
10:01 ET | 1652 | 46 |
10:03 ET | 1765 | 46 |
10:06 ET | 3801 | 45.59 |
10:08 ET | 2899 | 45.6 |
10:10 ET | 700 | 45.63 |
10:12 ET | 2650 | 45.4655 |
10:14 ET | 3462 | 45.54 |
10:15 ET | 600 | 45.58 |
10:17 ET | 1200 | 45.55 |
10:19 ET | 500 | 45.535 |
10:21 ET | 1707 | 45.565 |
10:24 ET | 500 | 45.6 |
10:26 ET | 1100 | 45.595 |
10:28 ET | 600 | 45.625 |
10:30 ET | 900 | 45.6425 |
10:32 ET | 1200 | 45.71 |
10:33 ET | 400 | 45.73 |
10:35 ET | 800 | 45.725 |
10:37 ET | 2300 | 45.6 |
10:39 ET | 1440 | 45.56 |
10:42 ET | 1000 | 45.545 |
10:44 ET | 300 | 45.58 |
10:46 ET | 800 | 45.575 |
10:48 ET | 423 | 45.58 |
10:50 ET | 1500 | 45.49 |
10:51 ET | 600 | 45.5 |
10:53 ET | 2600 | 45.57 |
10:55 ET | 400 | 45.57 |
10:57 ET | 1500 | 45.59 |
11:00 ET | 2614 | 45.625 |
11:02 ET | 2157 | 45.47 |
11:04 ET | 300 | 45.475 |
11:06 ET | 600 | 45.475 |
11:08 ET | 900 | 45.455 |
11:09 ET | 841 | 45.46 |
11:11 ET | 1300 | 45.445 |
11:13 ET | 1300 | 45.43 |
11:15 ET | 3020 | 45.365 |
11:18 ET | 1500 | 45.36 |
11:20 ET | 2341 | 45.41 |
11:22 ET | 300 | 45.36 |
11:24 ET | 965 | 45.4 |
11:26 ET | 1100 | 45.41 |
11:27 ET | 1132 | 45.4 |
11:29 ET | 2099 | 45.31 |
11:31 ET | 500 | 45.38 |
11:33 ET | 1800 | 45.4 |
11:36 ET | 500 | 45.38 |
11:38 ET | 1307 | 45.4 |
11:40 ET | 5842 | 45.2 |
11:42 ET | 1306 | 45.195 |
11:44 ET | 700 | 45.185 |
11:45 ET | 400 | 45.2 |
11:47 ET | 1235 | 45.16 |
11:49 ET | 3121 | 45.1746 |
11:51 ET | 3100 | 45.23 |
11:54 ET | 545 | 45.19 |
11:56 ET | 2500 | 45.175 |
11:58 ET | 2300 | 45.11 |
12:00 ET | 420 | 45.1 |
12:02 ET | 2196 | 45.1325 |
12:03 ET | 4847 | 45.27 |
12:05 ET | 936 | 45.315 |
12:07 ET | 516 | 45.38 |
12:09 ET | 500 | 45.43 |
12:12 ET | 600 | 45.495 |
12:14 ET | 1068 | 45.49 |
12:16 ET | 701 | 45.54 |
12:18 ET | 200 | 45.57 |
12:21 ET | 600 | 45.56 |
12:23 ET | 1221 | 45.54 |
12:25 ET | 800 | 45.495 |
12:27 ET | 600 | 45.53 |
12:30 ET | 110 | 45.515 |
12:32 ET | 1320 | 45.52 |
12:36 ET | 300 | 45.5 |
12:38 ET | 3845 | 45.49 |
12:39 ET | 100 | 45.48 |
12:41 ET | 2581 | 45.53 |
12:43 ET | 700 | 45.53 |
12:45 ET | 100 | 45.51 |
12:48 ET | 500 | 45.5 |
12:50 ET | 1300 | 45.435 |
12:52 ET | 1525 | 45.475 |
12:54 ET | 200 | 45.465 |
12:56 ET | 710 | 45.52 |
12:57 ET | 1351 | 45.47 |
12:59 ET | 100 | 45.51 |
01:01 ET | 1118 | 45.535 |
01:03 ET | 770 | 45.55 |
01:08 ET | 1015 | 45.56 |
01:10 ET | 100 | 45.54 |
01:12 ET | 4036 | 45.455 |
01:14 ET | 300 | 45.43 |
01:15 ET | 600 | 45.4625 |
01:17 ET | 400 | 45.48 |
01:19 ET | 400 | 45.465 |
01:21 ET | 1784 | 45.49 |
01:24 ET | 300 | 45.49 |
01:26 ET | 205 | 45.485 |
01:28 ET | 1250 | 45.52 |
01:30 ET | 1870 | 45.49 |
01:32 ET | 200 | 45.48 |
01:33 ET | 600 | 45.485 |
01:35 ET | 300 | 45.47 |
01:37 ET | 400 | 45.51 |
01:39 ET | 3455 | 45.42 |
01:42 ET | 100 | 45.37 |
01:44 ET | 5820 | 45.38 |
01:46 ET | 1300 | 45.41 |
01:48 ET | 400 | 45.42 |
01:50 ET | 600 | 45.46 |
01:51 ET | 1362 | 45.42 |
01:53 ET | 1649 | 45.3 |
01:57 ET | 100 | 45.28 |
02:00 ET | 107 | 45.24 |
02:02 ET | 700 | 45.16 |
02:04 ET | 800 | 45.12 |
02:06 ET | 636 | 45.08 |
02:08 ET | 800 | 45.03 |
02:09 ET | 1000 | 45 |
02:11 ET | 1600 | 44.96 |
02:13 ET | 801 | 44.955 |
02:15 ET | 819 | 44.95 |
02:18 ET | 872 | 44.91 |
02:20 ET | 2858 | 44.91 |
02:22 ET | 5314 | 44.76 |
02:24 ET | 2200 | 44.825 |
02:26 ET | 1300 | 44.895 |
02:27 ET | 600 | 44.92 |
02:29 ET | 400 | 44.945 |
02:31 ET | 100 | 44.95 |
02:33 ET | 1500 | 44.955 |
02:36 ET | 100 | 44.94 |
02:38 ET | 2000 | 44.895 |
02:40 ET | 2534 | 44.915 |
02:42 ET | 100 | 44.905 |
02:44 ET | 1104 | 44.9 |
02:45 ET | 2000 | 44.92 |
02:47 ET | 1410 | 44.96 |
02:49 ET | 500 | 44.95 |
02:51 ET | 300 | 44.955 |
02:54 ET | 2110 | 44.98 |
02:56 ET | 2729 | 45.07 |
02:58 ET | 1370 | 45.065 |
03:00 ET | 6253 | 45.2 |
03:02 ET | 1513 | 45.28 |
03:03 ET | 1526 | 45.29 |
03:05 ET | 2400 | 45.17 |
03:07 ET | 1000 | 45.2 |
03:09 ET | 1700 | 45.24 |
03:12 ET | 1237 | 45.205 |
03:14 ET | 636 | 45.19 |
03:16 ET | 800 | 45.23 |
03:18 ET | 2113 | 45.175 |
03:20 ET | 781 | 45.17 |
03:21 ET | 2632 | 45.19 |
03:23 ET | 1183 | 45.2 |
03:25 ET | 2682 | 45.17 |
03:27 ET | 500 | 45.16 |
03:30 ET | 900 | 45.11 |
03:32 ET | 1957 | 45.07 |
03:34 ET | 2813 | 45.07 |
03:36 ET | 1830 | 45.09 |
03:38 ET | 1600 | 45.09 |
03:39 ET | 710 | 45.12 |
03:41 ET | 6392 | 45.05 |
03:43 ET | 5269 | 45.13 |
03:45 ET | 397 | 45.14 |
03:48 ET | 2532 | 45.18 |
03:50 ET | 7153 | 45.14 |
03:52 ET | 3834 | 45.15 |
03:54 ET | 5539 | 45.18 |
03:56 ET | 14840 | 45.27 |
03:57 ET | 17539 | 45.19 |
03:59 ET | 19512 | 45.16 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 8.2B | -17.3x | --- |
Ascendis Pharma A/S | 7.1B | -12.5x | --- |
Blueprint Medicines Corp | 6.6B | -21.8x | --- |
Vaxcyte Inc | 8.1B | -17.7x | --- |
Cerevel Therapeutics Holdings Inc | 7.7B | -15.5x | --- |
Intra-Cellular Therapies Inc | 6.9B | -56.4x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.2B |
---|---|
Revenue (TTM) | $342.8M |
Shares Outstanding | 181.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.13 |
EPS | $-2.60 |
Book Value | $6.88 |
P/E Ratio | -17.3x |
Price/Sales (TTM) | 24.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -157.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.